Meneldor is a biopharmaceutical investment company .
Business Model:
Revenue: $0
Employees: 0-0
Address:
City:
State:
Zip:
Country:
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
11/2022 | Hemispherian | Series A | 3M |
6/2023 | Tagworks Pharmaceuticals | Series A | 65M |
6/2023 | Tagworks Pharmaceuticals | Series A | 0 |
6/2018 | Aptamer Group | Series A | 2.2M |
1/2019 | Atriva Therapeutics | Series A | - |
8/2020 | Atriva Therapeutics | Debt Financing | 10.1M |
5/2022 | Hemispherian | Seed Round | 0 |
5/2022 | Hemispherian | Seed Round | 0 |
8/2020 | Atriva Therapeutics | Debt Financing | 0 |
1/2019 | Atriva Therapeutics | Series A | - |
6/2018 | Aptamer Group | Series A | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|